Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300194 stock hub

SHE/300194 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300194is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.9B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300194

In the news

Latest news · SHE/300194

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E84.3

P25 23.5P50 41.3P75 83.2

ROE1.4

P25 -0.9P50 4.1P75 8.8

ROIC2

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300194 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

CNY

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,392
Employees Change	100%
Employees Change Percent	3.04
Enterprise value	CNY 4.6B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE1000011G4
Last refreshed	2026-05-10
Market cap	CNY 4.9B
Price	CNY 4.13
Price currency	CNY
Rev Per Employee	494,724.63x
Sector	Healthcare
Sic	2834
Symbol	she/300194
Website	https://www.fapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.28%
EV Earnings	73.85x
EV/EBIT	51.19x
EV/EBITDA	15.29x
EV/FCF	16.55x
EV/Sales	2.77x
FCF yield	5.71%
P/B ratio	1.11x
P/E ratio	84.28x
P/S ratio	2.93x
PE Ratio10 Y	29.32x
PE Ratio3 Y	30.01x
PE Ratio5 Y	28.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.4%
EBITDA Margin	17.68%
FCF margin	16.72%
Gross margin	36.79%
Gross Profit	CNY 617.4M
Gross Profit Growth	-40.86%
Gross Profit Growth Q	-13.21%
Gross Profit Growth3 Y	-24.26%
Gross Profit Growth5 Y	-17.02%
Net Income	CNY 62.9M
Net Income Growth	-72.23%
Net Income Growth Q	-20.47%
Net Income Growth Years	0%
Net Income Growth3 Y	-37.16%
Net Income Growth5 Y	-20.86%
Pretax Margin	4.15%
Profit Margin	3.75%
Profit Per Employee	CNY 18,533
Profitable Years	4
ROA	0.97
Roa5y	1.65
ROCE	1.88
ROE	1.41
Roe5y	0.94
ROIC	1.96
Roic5y	3.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.85%
Cagr15y	-1.68%
Cagr1y	1.69%
Cagr3y	0.42%
Cagr5y	0.67%
Div CAGR10	7.7%
Div CAGR3	11.87%
Div CAGR5	6.96%
EPS Growth	-74.95
EPS Growth Q	-23
EPS Growth Years	0
EPS Growth3 Y	-38.54
EPS Growth5 Y	-22.1
OCF Growth	110.49%
OCF Growth Q	215.45%
OCF Growth10 Y	6.38%
OCF Growth3 Y	20.05%
OCF Growth5 Y	24.83%
Revenue Growth	-18.13x
Revenue Growth Q	-12.87x
Revenue Growth Years	0x
Revenue Growth3 Y	-13.13x
Revenue Growth5 Y	-7.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.29
Assets	CNY 5.6B
Cash	CNY 919.6M
Current Assets	CNY 1.8B
Current Liabilities	CNY 807.7M
Debt	CNY 647.4M
Debt EBITDA	CNY 2.13
Debt Equity	CNY 0.15
Debt FCF	CNY 2.31
Equity	CNY 4.4B
Liabilities	CNY 1.2B
Long Term Assets	CNY 3.8B
Long Term Liabilities	CNY 400.1M
Net Cash	CNY 272.3M
Net Cash By Market Cap	CNY 5.54
Net Cash Growth	109%
Net Debt EBITDA	CNY -0.92
Net Debt Equity	CNY -0.06
Net Debt FCF	CNY -0.97
Tangible Book Value	CNY 3.8B
Tangible Book Value Per Share	CNY 3.22
WACC	5.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.25
Inventory Turnover	1.46
Net Working Capital	CNY 484.2M
Quick ratio	1.4
Working Capital	CNY 1B
Working Capital Turnover	CNY 1.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.84%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CNY 0.04
Dividend Years	3
Dividend Yield	0.97%
Ex Div Date	2025-09-25
Last Dividend	CNY 0.02
Payout Frequency	Annual
Payout Ratio	165.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-25.07%
1Y total return	1.69%
200-day SMA	4.47
3Y total return	1.28%
50-day SMA	4.2
50-day SMA vs 200-day SMA	50under200
5Y total return	3.39%
All Time High	13.66
All Time High Change	-69.76%
All Time High Date	2015-06-15
All Time Low	2.72
All Time Low Change	52.12%
All Time Low Date	2012-12-04
ATR	0.08
Beta	0.33
Beta1y	0.36
Beta2y	0.49
Ch YTD	-6.77
High	4.15
High52	5.48
High52 Date	2025-08-12
High52ch	-24.64%
Low	4.1
Low52	3.78
Low52 Date	2026-03-23
Low52ch	9.26%
Ma50ch	-1.55%
Price vs 200-day SMA	-7.63%
RSI	47.26
RSI Monthly	46.26
RSI Weekly	41.46
Sharpe ratio	-0.1x
Sortino ratio	0.09
Total Return	-9.87%
Tr YTD	-6.77
Tr15y	-22.45%
Tr1m	-3.5%
Tr1w	-0.48%
Tr3m	-7.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 90.7M
Operating Income Growth	-61.45
Operating Income Growth Q	-4.14
Operating Income Growth3 Y	-17.37
Operating Income Growth5 Y	-11.86
Operating margin	5.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	837,767,237%
Net Borrowing	-233,028,627
Shares Insiders	27.26%
Shares Institutions	0.57%
Shares Out	1,189,712,382
Shares Qo Q	-24.31%
Shares Yo Y	10.84%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 280.6M
Average Volume	14,620,042.85x
Bv Per Share	3.72
CAPEX	CNY -89.3M
Ch10y	-31.77
Ch15y	-32.02
Ch1m	-3.5
Ch1w	-0.48
Ch3m	-7.19
Ch3y	-2.82
Ch5y	-1.9
Ch6m	-10.22
Change	0.49%
Change From Open	0.49
Close	4.11
Days Gap	0
Depreciation Amortization	205,920,669
Dollar Volume	36,968,456
Earnings Date	2026-04-27
EBIT	CNY 90.7M
EBITDA	CNY 296.6M
EPS	CNY 0.05
F Score	6
FCF	CNY 280.6M
FCF EV Yield	6.04x
FCF Per Share	CNY 0.24
Financing CF	-349,473,305
Fiscal Year End	December
Founded	2,004
Goodwill	132,161,347
Graham Number	2.0257
Graham Upside	-50.95
Income Tax	CNY 7.2M
Investing CF	-248,031,130
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2017-05-10
Last Split Type	Forward
Lynch Fair Value	CNY 0.25
Lynch Upside	-94.07
Ma150	4.41
Ma150ch	-6.33%
Ma20	4.17
Ma20ch	-0.84%
Net CF	-227,919,013
Next Earnings Date	2026-08-28
Open	4.11
P FCF Ratio	17.51
P OCF Ratio	13.28
Payment Date	2025-09-25
Position In Range	60
Ppne	1,670,718,466
Price Date	2026-05-08
Price EBITDA	CNY 16.57
Ptbv Ratio	1.28
Relative Volume	0.58x
Revenue	1,678,105,959x
Tax By Revenue	0.43x
Tax Rate	10.34%
Tr6m	-10.22%
Volume	8,951,200

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300194 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.04 annual per share

Payout ratio

+165.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.0%

1 consecutive years of growth

Total shareholder yield

-9.9%

Next ex-dividend date: 2025-09-25

Performance

SHE/300194 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300194?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

+27.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.8%

Negative means the company is buying back shares.

Technical

SHE/300194 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-7.6%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

-0.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300194

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300194 stock rating?

she/300194 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300194 analysis?

The full report lives at /stocks/she/300194/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300194?

The latest report frames she/300194 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300194 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.